Trademark: 97447023
Word
CIFFABA
Status
Pending
Status Code
731
Status Date
Monday, May 13, 2024
Serial Number
97447023
Mark Type
4
Filing Date
Tuesday, June 7, 2022
Published for Opposition
Tuesday, April 18, 2023

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Mar 14, 2023
Assigned To Examiner
Jun 10, 2022
New Application Entered
Jun 16, 2022
New Application Office Supplied Data Entered
Mar 16, 2023
Approved For Pub - Principal Register
Mar 29, 2023
Notification Of Notice Of Publication E-Mailed
Apr 18, 2023
Published For Opposition
Apr 18, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 26, 2023
Teas Change Of Owner Address Received
Apr 26, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 26, 2023
Teas Change Of Correspondence Received
Apr 26, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 6, 2023
Assigned To Examiner
Jun 13, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 13, 2023
Sou Teas Extension Received
Nov 15, 2023
Notice Of Approval Of Extension Request E-Mailed
May 13, 2024
Sou Teas Extension Received
May 13, 2024
Sou Extension 2 Granted
May 13, 2024
Sou Extension 2 Filed
May 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2023
Sou Extension 1 Granted
Nov 13, 2023
Sou Extension 1 Filed

Trademark Alertz updated from USPTO on 2030-01-24